STERIS’ (TSE:STE – Free Report) – Investment analysts at Cormark dropped their FY2025 EPS estimates for shares of STERIS’ in a report released on Tuesday, November 5th. Cormark analyst B. Watson now forecasts that the company will post earnings of $0.94 per share for the year, down from their prior estimate of $1.02.
STERIS’ Stock Performance
STERIS’ (TSE:STE – Get Free Report) last announced its quarterly earnings results on Tuesday, August 6th. The company reported C$0.14 earnings per share for the quarter, beating the consensus estimate of C$0.12 by C$0.02. The business had revenue of C$231.38 million during the quarter, compared to the consensus estimate of C$226.20 million.
STERIS’ Company Profile
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
See Also
- Five stocks we like better than STERIS’
- Energy and Oil Stocks Explained
- AMD: The AI Disruptor – Is It Time to Follow Big Tech’s Lead?
- What is MarketRank™? How to Use it
- Analysts Signal Big Upside: Top 3 Stocks to Watch Right Now
- Transportation Stocks Investing
- Bears Misjudged These 3 ETFs: Where Investors Can Find Upside
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
